DYAI
DYADIC INTERNATIONAL INCCompany Information
- Company Name
- DYADIC INTERNATIONAL INC
- CIK
- CIK0001213809
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- DYAI: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- DYAI
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-08-01
- Last sale
- 2026-07-24
- Shares purchased (TTM)
- 26,000
- Shares sold (TTM)
- 2,616
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 4,625,718
- Shares outstanding
- 36,438,703
- Ownership
- 12.69%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -40.91%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 4 | 5 | 6 | 2 | 5 | 7 | 6 | 6 | 11 | 7 | 7 | ||||||
| Interest Receivable Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Short Term Investments | 2 | 1 | 3 | 3 | 3 | 2 | 3 | 4 | 4 | 1 | 1 | 1 | ||||||
| Restricted Cash | 2 | 1 | 1 | - | - | - | - | - | - | - | - | - | ||||||
| Restricted Cash Equivalents Current | - | 1 | - | 1 | 2 | - | - | - | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Accounts And Other Receivables Net Current | - | - | - | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Assets Current | 6 | 8 | 10 | 12 | 7 | 8 | 10 | 11 | 11 | 13 | 8 | 9 | ||||||
| Interest Receivable | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Receivables Net Current | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Investments And Other Noncurrent Assets | 0 | 0 | - | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Restricted Cash Equivalents Noncurrent | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Equity Securities F V N I Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 7 | 8 | 10 | 12 | 8 | 8 | 10 | 11 | 11 | 13 | 8 | 9 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 4 | 3 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | ||||||
| Contract With Customer Liability Current | 2 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Preferred Stock Value | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 9 | 8 | 9 | 9 | 9 | 7 | 7 | 7 | 7 | 8 | 2 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -2 | -0 | 1 | 3 | -1 | 1 | 2 | 3 | 3 | 5 | 6 | 8 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 114 | 114 | 114 | 113 | 108 | 108 | 107 | 107 | 106 | 106 | 105 | 105 | ||||||
| Treasury Stock Value | -19 | -19 | -19 | -19 | -19 | -19 | -19 | -19 | -19 | -19 | -19 | -19 | ||||||
| Retained Earnings Accumulated Deficit | -98 | -95 | -93 | -92 | -90 | -88 | -86 | -85 | -84 | -82 | -80 | -78 | ||||||
| Liabilities And Stockholders Equity | 7 | 8 | 10 | 12 | 8 | 8 | 10 | 11 | 11 | 13 | 8 | 9 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | - | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | - | - | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | - | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 49 | 49 | 48 | 48 | 42 | - | 42 | 42 | 42 | 41 | 41 | 41 | ||||||
| Shares Outstanding | 36 | 36 | 36 | 36 | 30 | - | 30 | 30 | 29 | 29 | 29 | 29 | ||||||
| Treasury Stock Common Shares | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialDYADIC INTERNATIONAL INC (DYAI) — SEC Financial Statements & Analysis
DYADIC INTERNATIONAL INC (DYAI) is a biological products, (no diagnostic substances) company, incorporated in DE. DYADIC INTERNATIONAL INC trades on Nasdaq as: DYAI. DYADIC INTERNATIONAL INC (DYAI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, DYADIC INTERNATIONAL INC carries a market cap of $43.82M, a P/E ratio of -5.75x, a P/B ratio of -18.36x, a P/S ratio of 11.53x, an enterprise value of $40.84M, and an EV/EBITDA multiple of -5.51x. On profitability, it posts a gross margin of 66.88%, an operating margin of -195.10%, a net margin of -200.46%, a Return on Equity (ROE) of 522.59%, and a Return on Assets (ROA) of -103.88%. Per share, it reports EPS of $-0.16, diluted EPS of $-0.21, free cash flow per share of $-0.15, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -8.05% year-over-year, net income growth of 36.70% year-over-year, and EPS growth of 19.00% year-over-year. On the balance sheet, it maintains a current ratio of 1.65x, a quick ratio of 1.54x, working capital of $2.52M, a debt-to-equity ratio of -3.74x, a debt ratio of 1.37, an interest coverage ratio of -26.29x, free cash flow of $-7.40M (TTM), and net debt of $-2.98M. Figures sourced from SEC EDGAR.
- Market Cap
- $43.82M
- P/E TTM
- -5.75x
- EPS TTM
- $-0.16
- P/B TTM
- -18.36x
- ROE TTM
- 522.59%
- ROA TTM
- -103.88%
- Debt To Equity
- -3.74x
- Free Cash Flow TTM
- $-7.40M
- Net Revenue TTM Growth 1Y
- -8.05%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is DYADIC INTERNATIONAL INC in?
DYADIC INTERNATIONAL INC (DYAI) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does DYAI trade on?
DYADIC INTERNATIONAL INC (DYAI) trades on the Nasdaq.
Where is DYADIC INTERNATIONAL INC incorporated?
DYADIC INTERNATIONAL INC is incorporated in DE.
When was DYADIC INTERNATIONAL INC (DYAI)'s most recent SEC filing?
DYADIC INTERNATIONAL INC (DYAI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is DYAI's market cap?
DYADIC INTERNATIONAL INC (DYAI) has a market capitalization of $43.82M as of 2026-06-30.
What is DYAI's EPS (earnings per share)?
DYADIC INTERNATIONAL INC (DYAI)'s trailing twelve month EPS is $-0.16 as of 2026-06-30.
What is DYAI's ROE (return on equity)?
DYADIC INTERNATIONAL INC (DYAI)'s trailing twelve month Return on Equity (ROE) is 522.59% as of 2026-06-30.
What is DYAI's ROA (return on assets)?
DYADIC INTERNATIONAL INC (DYAI)'s trailing twelve month Return on Assets (ROA) is -103.88% as of 2026-06-30.
What is DYAI's EV/EBITDA?
DYADIC INTERNATIONAL INC (DYAI)'s trailing twelve month EV/EBITDA is -5.51x as of 2026-06-30.